Growth Hormone Disorders Terminated Phase 4 Trials for Somatotropin (DB00052)

Also known as: Growth Hormone Disorder

IndicationStatusPhase
DBCOND0036845 (Growth Hormone Disorders)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01698944Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone DeficiencyTreatment